Understanding of molecular mechanisms regulating utrophin expression may have therapeutic benefit because of utrophin’s potential to functionally compensate dystrophin deficiency in DMD. This evidence concerns the gene UTRN and hyperinsulinemic hypoglycemia, familial, 4.